Member Info for BlahBlahDoh

Despite completing £50m+ property sales, suspension continues for now.
Market has moved on, looking forward to results due 10th March, with a loadsamoney dividend expected.

One other thing - Finablr have connections with Airtel Africa (AAF), who are also down a tad, possibly for similar reasons?

Thanks for clarifying Aquae, good spot.

AquaeSulis01 got the company name wrong, and also Finablr do not have the same CEO as NMC Healthcare, casting doubt on the confident reason given for their share price fall. Interesting company though. Good luck all.
https://www.entrepreneur.com/author/promoth-manghat
https://nmc.ae/senior-management/prasanth-manghat-8

"Hi Troubles
The market is no guide at all"

It was actually me who said "the market is the best guide we have". I didn't necessarily say it was a good guide, but it's certainly better than none, or some of the fantasy figures being dreamed up by optimistic punters. Some commentators seem to view this as a company with a stable of proven winners, thoroughbred patents with immense stud value which mysterious oriental bidders are desperately pursuing in an almighty battle for supremacy, vying for ownership of this handsome champion. In reality, they are flogging a horse which, while not quite dead, has already fallen at quite a few fences, and looking a bit frothy at the mouth. In all likelihood they are having to offer good odds to attract any bets. They'll probably also need a few sugar cubes, or perhaps an apple, to get this tired old nag over the line.

i would suggest the market is the best guide we have. It seems unlikely that interested parties, or anyone connected with them, see the value very much higher yet have abstained from buying. A small premium to the current price gives something around 14.5p

A classicly uninformative Nano missive. So they were talking to several parties, and now they are going to continue to talk to several parties. No change there then, but now instead of a vague deadline of mid-December, we have none. While accepting there is a need for due diligence, one might have expected that that had already happened, given the elapsed time. How many more stages before they actually make a decision, which is after all, their only job. For people who pay themselves so much money, the board seem to give themselves a very low level of responsibilities or imposition of schedules.

Regarding "The Board has reviewed the proposals and is now inviting certain of those parties to engage in further due diligence and detailed discussions about the sale of the Company”, one interpretation could be that different parties might be interested in different parts of the business?

Venn diagram is mORPHing.

The slight easing in the trade war seems to have propelled the Hang Seng higher for a whole week, and the effect on Pru seems to be a tenuous, delayed correlation? In truth, the latest "deal" seems to merely involve the US withdrawing extra sanctions which they had already postponed once, and the Chinese agreeing to buy agricultural produce which they needed anyway due to domestic problems. But hey, we'll take it! There may possibly be some pressure on Trump to soften the trade war in order to shore up his deteriorating position ahead of next years election. Let's hope this allows Pru a window to demonstrate to the market their true growth credentials, because growth stocks are normally valued a lot higher than Pru currently is.

The forces of darkness are once more swarming all over this share, with half a dozen upping their short exposure and a huge total of 6.85%. The heady rally seems to have driven them into a frenzy of increased negativity. Oops downside yer head.

"Buy Nanoco now, join the optical revolution in 20:20". See, that's the way to sell 'em, not with hackneyed old cliches.

Thanks bobf, for tolerating my pedantry in good spirit! Well done for running the competition and Happy Xmas.

MEs recent PR material is similar to what he has been saying every year for over a decade. Given the actual shareholder return over that period, it might be wise to take it with a pinch of salt. The issue of aesthetics is clearly important to Apple, but it is hardly relevant to nanotechnology, which no-one can see. The fact that the cancellation was unrelated to Nano's material is well known, was publicly announced, and has not changed. So why the sudden urgency now, the awestruck quotations of ME's wisdom, and the ridiculous, overexcited hawkers language: "Massive opp here. Miss out at YOUR own peril" and so on? It's almost as if you are trying to mislead the uninformed into buying, for some reason.

Their profiles reveal that Munchbox has been around longer than both IreneKrapp and Slavetothetrade, and comments on different shares. Making false accusations about them shows a lack of reasoning or judgement (or research), and a fundamental lack of respect. The board is for discussing Blue Prism, not uninformed malice.

With that in mind: despite reservations over the software, Blue Prism may still have some value simply due to it's position in the market. Many companies have prevailed despite not being the best technically. I'm thinking of Microsoft and Sage, for example. Other companies have burned money for years before reaping huge rewards too. A lot depends on the stamina and pockets of the big backers. So far, Blue Prism seem adequately supported, and the growing client list holds out at least the possibility of the prism eventually refracting blue light instead of pure red. Given how far off profitability realistically is though, the soaring price lost touch with logic a long time ago, and seems driven purely by sentiment at present.

The rns of 15 Nov said "redT shares valued at 1.65 pence each, valuing Avalon at USD37.5 million."
At that price MattTheBrave would be the winner?

Scott McGregor is due to leave December 31, any chance of movement early next year, and the commencement of the Larry Zulch era? Rather Zulch than zilch.

The Fat Controller smiled at everyone and said "his role is to get maximum value for shareholders ". Thomas just rolled his eyes.

Apple's "willingness to buy" strategically important technology contrasts rather sadly with Evercore's task of finding buyers on Nano's behalf. Perhaps Nano should move to Cambridge, as Apple seem to prefer companies from there (:

Here's hoping rapid movement on Brexit and the Trade War bring greater investment worldwide and to the UK particularly, consequently leading to better prospects for nano next year.

Housebuilders were the biggest risers on Friday: Berkeley were up over 13%. M&G were unfortunate they couldn't hold off suspension for just 11 more days, but maybe they will now be able to lift it sooner than expected?

The offer seems to be for 100% of HVOs shares, with no exclusions. According to the admission document you referenced , that includes a 49% share of Imutex, and also 62.62% of PrEP Biopharm Ltd as part of the proposed Enlarged Group.

I have no idea what was in the "taken down" interview, but if it suggested anything contrary to the admission document then that is presumably why it was taken down? Ideally, clarification ought to be forthcoming if somebody "mis-spoke", but it can probably be discounted as one of those embarrassing mistakes we are all prone to.

Looks like Cionnathagad's posts have been erased? Unfortunately that renders this thread unintelligible. Presumably rules were broken, but it's a shame an apparently knowledgeable dissenting voice had to be been silenced, as it is often instructive to hear and test opposing views. One thing C was worried about was excessive borrowing for growth via acquisition. Frankly, anyone thinking that way should have simply sold up and invested elsewhere, as the company strategy is clearly stated as rapid expansion to reach critical mass. As it turns out, ORPH have begun to achieve their objective by successfully offering shares instead, which was always a predictable option. The first such acquisition could be seen as the hardest, overcoming inertia, but successful integration, if achieved quickly, will put ORPH in a stronger position for the next, and from then on momentum can drive the process. Surely all the founders experience and separate skills are valuable in this tricky process? As C isn't here to justify incorrect assumptions, can we assume they would be contrite, apologetic, and humbled by events? We'll never know. Of course, it's too early to guess if ORPH will turn out well, but so far they are doing exactly what they said they would, promptly. Long may it continue.